HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RNF213 inhibits migration in lung adenocarcinoma cell.

Abstract
Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors, and lung adenocarcinoma (LUAD) accounts for up to 40% of NSCLC. Ring finger protein 213(RNF213) has been demonstrated to suppress several cancers, including glioblastoma and breast cancer. Nonetheless, the role of RNF213 in LUAD has not been investigated. The expression of RNF213 in LUAD tissues was analyzed by western blotting, The Cancer Genome Atlas, Genotype Tissue Expression Project, and Gene Expression Omnibus databases. Prognostic value analysis was performed through the Kaplan-Meier Plotter database. We determined the role of RNF213 in LUAD cells through cell counting kit‑8 assay, migration, and invasion assay. The clinical roles of RNF213 were evaluated by immunohistochemical staining assay (IHC) and Kaplan-Meier survival analysis. RNF213 expression was reduced in LUAD, thus affecting the prognosis of LUAD. And RNF213 could suppress the migration and invasion of LUAD cells to prevent tumor development. the expression of RNF213 is positively correlated with the overall survival, providing a novel marker in the prognosis of LUAD patients.
AuthorsXiaoli Liu, Huanwen Zeng, Zizi Li, Chunren Wei, Zhaoyuan Zhang, Xiaodong Liu, Nan Chen
JournalCellular and molecular biology (Noisy-le-Grand, France) (Cell Mol Biol (Noisy-le-grand)) Vol. 69 Issue 14 Pg. 286-292 (Dec 20 2023) ISSN: 1165-158X [Electronic] France
PMID38279417 (Publication Type: Journal Article)
Chemical References
  • Adenosine Triphosphatases
  • RNF213 protein, human
  • Transcription Factors
  • Ubiquitin-Protein Ligases
Topics
  • Humans
  • Adenocarcinoma of Lung (metabolism, pathology)
  • Adenosine Triphosphatases (metabolism)
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms (metabolism, pathology)
  • Transcription Factors
  • Ubiquitin-Protein Ligases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: